BioAge Labs, Inc. Common Stock (BIOA)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 62
- Market Cap
- $488M
About BioAge Labs, Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
SentiSense also tracks daily options readings for BioAge Labs, Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
BioAge Labs, Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.